$PETS
PETMED EXPRESS INC Stock $pets

$pets Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000104013024000069 Filed on August 07, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2023 Q4
Revenue	$59.57M	$67.95M	$65.32M
YoY Change	-16.1%	-13.15%	10.95%
Cost Of Revenue	$42.26M	$49.98M	$47.43M
YoY Change	-17.04%	-10.3%	8.71%
Gross Profit	$17.31M	$17.97M	$17.88M
YoY Change	-13.71%	-20.22%	17.36%
Gross Profit Margin	29.06%	26.45%	27.38%
Selling, General & Admin	$15.10M	$11.86M	$19.19M
YoY Change	-19.64%	-48.36%	27.35%
% of Gross Profit	87.22%	66.02%	107.29%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.658M	$1.721M	$1.770M
YoY Change	-3.21%	2.56%	88.1%
% of Gross Profit	9.58%	9.58%	9.9%
Operating Expenses	$16.76M	$13.59M	$20.96M
YoY Change	-18.27%	-44.9%	30.92%
Operating Profit	$554.0K	$4.386M	-$3.074M
YoY Change	-225.62%	-306.11%	299.74%
Interest Expense	$185.0K	$95.00K	$136.0K
YoY Change	-67.54%	-84.68%	-80.79%
% of Operating Profit	33.39%	2.17%
Other Income/Expense, Net	$371.0K	$326.0K	$429.0K
YoY Change	-54.98%	-35.57%	-55.64%
Pretax Income	$925.0K	$4.712M	-$2.645M
YoY Change	141.51%	-570.26%	-1435.86%
Income Tax	-$1.400M	$1.000M	-$600.0K
% Of Pretax Income	-151.35%	21.22%
Net Earnings	$2.326M	$3.754M	-$2.027M
YoY Change	-3422.86%	-523.22%	10568.42%
Net Earnings / Revenue	3.9%	5.52%	-3.1%
Basic Earnings Per Share	$0.11	$0.18	-$0.10
Diluted Earnings Per Share	$0.11	$0.18	-$0.10
COMMON SHARES
Basic Shares Outstanding	20.60M shares	21.15M shares	21.15M shares
Diluted Shares Outstanding	20.94M shares	20.94M shares	20.43M shares

Balance Sheet

Concept	2024 Q3	2024 Q2	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$52.05M	$45.99M	$49.44M
YoY Change	-2.72%	-25.26%	-51.73%
Cash & Equivalents	$52.00M	$46.00M	$49.40M
Short-Term Investments
Other Short-Term Assets	$4.022M	$3.851M	$9.602M
YoY Change	-63.77%	-61.79%	32.53%
Inventory	$13.09M	$25.52M	$34.58M
Prepaid Expenses
Receivables	$1.620M	$2.261M	$1.930M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$70.78M	$77.62M	$95.55M
YoY Change	-17.37%	-26.65%	-28.7%
LONG-TERM ASSETS
Property, Plant & Equipment	$26.20M	$26.11M	$26.81M
YoY Change	-2.83%	-10.68%	6.22%
Goodwill	$26.66M	$26.66M	$26.66M
YoY Change	18.74%	28.57%
Intangibles	$10.22M	$10.71M	$11.69M
YoY Change	-16.07%	-15.44%
Long-Term Investments			$5.300M
YoY Change
Other Assets	$5.681M	$5.012M	$5.715M
YoY Change	9.25%	-31.06%
Total Long-Term Assets	$75.26M	$75.09M	$77.80M
YoY Change	2.23%	0.24%	150.15%
TOTAL ASSETS
Total Short-Term Assets	$70.78M	$77.62M	$95.55M
Total Long-Term Assets	$75.26M	$75.09M	$77.80M
Total Assets	$146.0M	$152.7M	$173.4M
YoY Change	-8.31%	-15.5%	4.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$16.95M	$24.47M	$38.85M
YoY Change	-33.21%	-38.89%	59.77%
Accrued Expenses	$30.23M	$30.97M	$30.48M
YoY Change	158.38%	120.6%	351.3%
Deferred Revenue	$1.600M	$2.100M	$3.100M
YoY Change	-55.56%	-34.38%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$48.83M	$58.30M	$72.40M
YoY Change	20.0%	1.71%	133.01%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$768.0K	$883.0K	$890.0K
YoY Change	-79.92%	-82.66%
Total Long-Term Liabilities	$768.0K	$883.0K	$890.0K
YoY Change	-79.92%	-82.66%
TOTAL LIABILITIES
Total Short-Term Liabilities	$48.83M	$58.30M	$72.40M
Total Long-Term Liabilities	$768.0K	$883.0K	$890.0K
Total Liabilities	$49.60M	$59.18M	$73.29M
YoY Change	8.77%	-5.18%	132.4%
SHAREHOLDERS EQUITY
Retained Earnings	$78.89M	$76.56M	$76.56M
YoY Change	-14.14%	-22.08%	-34.52%
Common Stock	$21.00K	$21.00K	$21.00K
YoY Change	0.0%	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$96.43M	$93.53M	$100.1M
YoY Change
Total Liabilities & Shareholders Equity	$146.0M	$152.7M	$173.4M
YoY Change	-8.31%	-15.5%	4.98%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2023 Q4
OPERATING ACTIVITIES
Net Income	$2.326M	$3.754M	-$2.027M
YoY Change	-3422.86%	-523.22%	10568.42%
Depreciation, Depletion And Amortization	$1.658M	$1.721M	$1.770M
YoY Change	-3.21%	2.56%	88.1%
Cash From Operating Activities	$7.389M	-$8.517M	-$2.588M
YoY Change	-1047.31%	-1615.48%	-119.95%
INVESTING ACTIVITIES
Capital Expenditures	$1.265M	$683.0K	$1.120M
YoY Change	27.78%	-40.76%	12.79%
Acquisitions		$0.00
YoY Change		-100.0%
Other Investing Activities	$0.00	$0.00	-$299.0K
YoY Change		-100.0%
Cash From Investing Activities	-$1.265M	-$683.0K	-$1.419M
YoY Change	27.78%	-98.15%	42.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-71.00K	-$104.0K	-19.00K
YoY Change	-98.87%	-98.3%	-99.69%
NET CHANGE
Cash From Operating Activities	7.389M	-$8.517M	-2.588M
Cash From Investing Activities	-1.265M	-$683.0K	-1.419M
Cash From Financing Activities	-71.00K	-$104.0K	-19.00K
Net Change In Cash	6.053M	-$9.304M	-4.026M
YoY Change	-175.01%	-78.13%	-168.45%
FREE CASH FLOW
Cash From Operating Activities	$7.389M	-$8.517M	-$2.588M
Capital Expenditures	$1.265M	$683.0K	$1.120M
Free Cash Flow	$6.124M	-$9.200M	-$3.708M
YoY Change	-445.99%	1456.68%	-130.96%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	28556000	usd
CY2024Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	49981000	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	55718000	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	17971000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	22526000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	55296000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	104086000	usd
CY2024Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	25520000	usd
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20600652	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20600652	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21148692	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21148692	shares
CY2024Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	717000	usd
CY2024Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	0	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	58300000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	72158000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	883000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	995000	usd
CY2024Q2	us-gaap	Liabilities Liabilities	59183000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	73153000	usd
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	2500	shares
CY2024Q2	us-gaap	Share Based Compensation ShareBasedCompensation	-8204000	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	1760000	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4874000	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	15711000	usd
CY2024Q2	us-gaap	Advertising Expense AdvertisingExpense	6990000	usd
CY2023Q2	us-gaap	Advertising Expense AdvertisingExpense	7265000	usd
CY2024Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1721000	usd
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1678000	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	13585000	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	24654000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	4386000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2128000	usd
CY2024Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	95000	usd
CY2023Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	194000	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	231000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	506000	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	326000	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	700000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4712000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1428000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	958000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-292000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	3754000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1136000	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.18
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.18
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20513281	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20332526	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20941505	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20332526	shares
CY2024Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0
CY2023Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.30
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	3754000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1136000	usd
CY2024Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1721000	usd
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1678000	usd
CY2024Q2	us-gaap	Share Based Compensation ShareBasedCompensation	-8204000	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	1760000	usd
CY2024Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-26000	usd
CY2023Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-627000	usd
CY2024Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	142000	usd
CY2023Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	19000	usd
CY2024Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-880000	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	46000	usd
CY2024Q2	us-gaap	Increase Decrease In Finished Goods And Work In Process Inventories IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories	-3036000	usd
CY2023Q2	us-gaap	Increase Decrease In Finished Goods And Work In Process Inventories IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories	10185000	usd
CY2024Q2	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	-188000	usd
CY2023Q2	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	-335000	usd
CY2024Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2474000	usd
CY2023Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2390000	usd
CY2024Q2	pets	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	-135000	usd
CY2023Q2	pets	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	-196000	usd
CY2024Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-12558000	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	9115000	usd
CY2024Q2	us-gaap	Increase Decrease In Property And Other Taxes Payable IncreaseDecreaseInPropertyAndOtherTaxesPayable	319000	usd
CY2023Q2	us-gaap	Increase Decrease In Property And Other Taxes Payable IncreaseDecreaseInPropertyAndOtherTaxesPayable	500000	usd
CY2024Q2	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-505000	usd
CY2023Q2	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	1295000	usd
CY2024Q2	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-133000	usd
CY2023Q2	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-205000	usd
CY2024Q2	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-457000	usd
CY2023Q2	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	253000	usd
CY2024Q2	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	717000	usd
CY2023Q2	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	0	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8517000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	562000	usd
CY2024Q2	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2023Q2	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	35859000	usd
CY2024Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	683000	usd
CY2023Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1153000	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-683000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-37012000	usd
CY2024Q2	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	104000	usd
CY2023Q2	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	6102000	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-104000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-6102000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-9304000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-42552000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	45992000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	61534000	usd
CY2024Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	81000	usd
CY2023Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2024Q2	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	112000	usd
CY2023Q2	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	1507000	usd
CY2024Q2	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates </span></div>The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2100000	usd
CY2024Q2	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	reporting_unit
CY2024Q2	pets	Revenue From Contract With Customer Number Of Performance Obligations RevenueFromContractWithCustomerNumberOfPerformanceObligations	1	performanceobligation
CY2024Q2	pets	Revenue From Contract With Customer Number Of Membership Models RevenueFromContractWithCustomerNumberOfMembershipModels	2	model
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2600000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	67952000	usd
CY2024Q2	pets	Revenue From Contract With Customer Percentage RevenueFromContractWithCustomerPercentage	1.000
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	78244000	usd
CY2023Q2	pets	Revenue From Contract With Customer Percentage RevenueFromContractWithCustomerPercentage	1.000
CY2024Q2	pets	Revenue From Contract With Customer Variance RevenueFromContractWithCustomerVariance	-10292000	usd
CY2024Q2	pets	Revenue From Contract With Customer Variance Percentage RevenueFromContractWithCustomerVariancePercentage	-0.132
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	3754000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1136000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20513281	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20332526	shares
CY2024Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	418099	shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2024Q2	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	10125	shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	0	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20941505	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20332526	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.18
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.18
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	46000000.0	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	55300000	usd
CY2024Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	13160000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2446000	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	10714000	usd
CY2024Q2	pets	Intangible And Other Assets Gross IntangibleAndOtherAssetsGross	18460000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2446000	usd
CY2024Q2	pets	Intangible And Other Assets IntangibleAndOtherAssets	16014000	usd
CY2024Q1	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	13160000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1957000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	11203000	usd
CY2024Q1	pets	Intangible And Other Assets Gross IntangibleAndOtherAssetsGross	18460000	usd
CY2024Q1	pets	Intangibles And Other Assets Accumulated Amortization IntangiblesAndOtherAssetsAccumulatedAmortization	1957000	usd
CY2024Q1	pets	Intangible And Other Assets IntangibleAndOtherAssets	16503000	usd
CY2024Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	500000	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	500000	usd
CY2022Q2	pets	Term Of Agreement TermOfAgreement	P3Y
CY2022Q2	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	5000000.0	usd
CY2023Q4	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	300000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	5300000	usd
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y9M18D
CY2024Q2	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.036
CY2024Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	148000	usd
CY2024Q2	us-gaap	Variable Lease Cost VariableLeaseCost	14000	usd
CY2024Q2	us-gaap	Lease Cost LeaseCost	162000	usd
CY2024Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	145000	usd
CY2024Q2	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2220000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	501000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	488000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	502000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	42000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1533000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	212000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1321000	usd
CY2024Q2	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	0	shares
CY2023Q2	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	0	shares
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1000000.0	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-300000	usd
CY2024Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.203
CY2023Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.204
CY2024Q2	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-1800000	usd
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001040130-24-000069-index-headers.html	Edgar Link	pending
0001040130-24-000069-index.html	Edgar Link	pending
0001040130-24-000069.txt	Edgar Link	pending
0001040130-24-000069-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pets-20240630.htm	Edgar Link	pending
pets-20240630.xsd	Edgar Link	pending
pets-20240630xexx311.htm	Edgar Link	pending
pets-20240630xexx312.htm	Edgar Link	pending
pets-20240630xexx321.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
pets-20240630_cal.xml	Edgar Link	unprocessable
pets-20240630_def.xml	Edgar Link	unprocessable
pets-20240630_lab.xml	Edgar Link	unprocessable
pets-20240630_pre.xml	Edgar Link	unprocessable
pets-20240630_htm.xml	Edgar Link	completed
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PETS
PETMED EXPRESS INC Stock $pets

2024 Q3 Form 10-Q Financial Statement

#000104013024000069 Filed on August 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PETS PETMED EXPRESS INC Stock $pets

2024 Q3 Form 10-Q Financial Statement

#000104013024000069 Filed on August 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PETS
PETMED EXPRESS INC Stock $pets